Jefferies hikes price target and outlook for Australia's Sonic Healthcare
Jefferies raised its price target for Sonic Healthcare to A$22.4 from A$21, kept its hold rating and lifted its fiscal 2027 and 2028 earnings-per-share estimates by about 1% each. Sonic reaffirmed its fiscal 2027 EBITDA guidance at its annual general meeting.
1. Jefferies raises estimates
Jefferies raised its price target for Sonic Healthcare to A$22.4 from A$21 and maintained its hold rating. The brokerage also lifted its earnings-per-share estimates by around 1% for each of fiscal 2027 and 2028.
2. Company outlook
Sonic reaffirmed fiscal 2027 EBITDA guidance at its annual general meeting. Jefferies said margin expansion was being achieved as expected, German and Swiss synergies were progressing, and US operating review initiatives were on track. The brokerage also cited ongoing cash generation and an improved outlook for further corporate activity over the medium term, while noting continued challenges in net profit growth.





